Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
M
MPAL
vs
F
FTSE All Share Index
Over the past 12 months, MPAL has outperformed FTSE All Share Index, delivering a return of -36% compared to FTSE All Share Index's 0% growth.
Stocks Performance
MPAL vs FTSE All Share Index
Performance Gap
MPAL vs FTSE All Share Index
Performance By Year
MPAL vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medpal AI PLC
Glance View
Medpal AI PLC appears to build software that uses artificial intelligence to help people handle health-related tasks more easily. In plain terms, it is a healthcare software company, not a drug maker or hospital operator. Its value comes from turning medical information, reminders, and routine support into digital tools that patients and clinicians can use day to day. The company likely sells its software and related services to healthcare providers, clinics, insurers, and possibly employers or patients who want digital health support. It would make money through software subscriptions, usage-based fees, or contracts to license its tools and support them over time. That model tends to be attractive because the same software can serve many users once it is built. What makes a business like this different is that it sits between healthcare and technology. Instead of treating patients directly, it packages software that helps organize care, improve communication, and reduce manual work for healthcare teams. That puts Medpal AI in the role of a specialist tool provider inside the broader healthcare system.